CODX stock is the biggest gainer on the Nasdaq after Co-Diagnostics Inc (NASDAQ:CODX) announced favorable results from a study to detect cancer mutations using its CoPrimer technology.
Key DevelopmentMolecular diagnostics company Co-Diagnostics Inc, which has also created a patented platform meant for molecular diagnostics, made a significant announcement this morning. The company announced that its proprietary technology known as CoPrimer was put through a study aimed at detecting cancer mutations and the study has proven to be positive. CoPrimer could also have applications in associated diagnostics tests and also for liquid biopsy, which is why ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.